Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Psyched Wellness ( (TSE:PSYC) ) has issued an announcement.
Psyched Wellness Ltd. announced the completion of an initial pilot run for a new dietary supplement shot through its US subsidiary, AME Wellness Inc. The pilot aims to test the product with a select group of consumers and gather feedback on various aspects, including taste and marketing data. The company is also preparing its fulfillment capabilities ahead of the product’s official launch, indicating a strategic move to expand its market presence and partnerships.
More about Psyched Wellness
Psyched Wellness Ltd. is a Canadian-based life sciences company specializing in health supplements derived from the Amanita Muscaria mushroom. The company focuses on researching and producing consumer packaged goods products, particularly their proprietary extract, AME-1.
YTD Price Performance: 10.0%
Average Trading Volume: 49,276
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.07M
For an in-depth examination of PSYC stock, go to TipRanks’ Stock Analysis page.